These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12517802)

  • 41. [Effect of up-regulation of S-AdoMet synthetase on taxol-induced apoptosis in human breast cancer cells].
    Chen L; Zheng S; Fan W
    Zhonghua Zhong Liu Za Zhi; 1998 Jan; 20(1):28-30. PubMed ID: 10921051
    [TBL] [Abstract][Full Text] [Related]  

  • 42. BRCA1 modulates malignant cell behavior, the expression of survivin and chemosensitivity in human breast cancer cells.
    Promkan M; Liu G; Patmasiriwat P; Chakrabarty S
    Int J Cancer; 2009 Dec; 125(12):2820-8. PubMed ID: 19551867
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Downregulation of survivin expression and enhanced chemosensitivity of MCF-7 cells to adriamycin by PDMAE/survivin shRNA complex nanoparticles.
    Yang Y; Gao Y; Chen L; Huang Y; Li Y
    Int J Pharm; 2011 Feb; 405(1-2):188-95. PubMed ID: 21130850
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin.
    O'Connor DS; Grossman D; Plescia J; Li F; Zhang H; Villa A; Tognin S; Marchisio PC; Altieri DC
    Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13103-7. PubMed ID: 11069302
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Potentiation of paclitaxel-induced apoptosis by the novel cyclin-dependent kinase inhibitor NU6140: a possible role for survivin down-regulation.
    Pennati M; Campbell AJ; Curto M; Binda M; Cheng Y; Wang LZ; Curtin N; Golding BT; Griffin RJ; Hardcastle IR; Henderson A; Zaffaroni N; Newell DR
    Mol Cancer Ther; 2005 Sep; 4(9):1328-37. PubMed ID: 16170024
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Survivin is regulated by interleukin-4 in colon cancer stem cells.
    Di Stefano AB; Iovino F; Lombardo Y; Eterno V; Höger T; Dieli F; Stassi G; Todaro M
    J Cell Physiol; 2010 Nov; 225(2):555-61. PubMed ID: 20506498
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of survivin expression suppresses the growth of aggressive non-Hodgkin's lymphoma.
    Ansell SM; Arendt BK; Grote DM; Jelinek DF; Novak AJ; Wellik LE; Remstein ED; Bennett CF; Fielding A
    Leukemia; 2004 Mar; 18(3):616-23. PubMed ID: 14749704
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Small interfering RNA targeting survivin sensitizes lung cancer cell with mutant p53 to adriamycin.
    Yonesaka K; Tamura K; Kurata T; Satoh T; Ikeda M; Fukuoka M; Nakagawa K
    Int J Cancer; 2006 Feb; 118(4):812-20. PubMed ID: 16108013
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sequential combination of flavopiridol and docetaxel reduces the levels of X-linked inhibitor of apoptosis and AKT proteins and stimulates apoptosis in human LNCaP prostate cancer cells.
    Gomez LA; de Las Pozas A; Perez-Stable C
    Mol Cancer Ther; 2006 May; 5(5):1216-26. PubMed ID: 16731754
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeting survivin in cancer: patent review.
    Kanwar JR; Kamalapuram SK; Kanwar RK
    Expert Opin Ther Pat; 2010 Dec; 20(12):1723-37. PubMed ID: 21083520
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A p34(cdc2) survival checkpoint in cancer.
    O'Connor DS; Wall NR; Porter AC; Altieri DC
    Cancer Cell; 2002 Jul; 2(1):43-54. PubMed ID: 12150824
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A study of cytotoxic synergy of UCN-01 and flavopiridol in syngeneic pair of cell lines.
    Wu K; D'Amico M; Wang C; Albanese C; Pestell RG; Mani S
    Invest New Drugs; 2005 Aug; 23(4):299-309. PubMed ID: 16012789
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prostate-derived Ets transcription factor (PDEF) downregulates survivin expression and inhibits breast cancer cell growth in vitro and xenograft tumor formation in vivo.
    Ghadersohi A; Pan D; Fayazi Z; Hicks DG; Winston JS; Li F
    Breast Cancer Res Treat; 2007 Mar; 102(1):19-30. PubMed ID: 16897429
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Changes of survivin mRNA and protein expression during paclitaxel treatment in breast cancer cells.
    Xiong H; Yu S; Zhuang L; Xiong H
    J Huazhong Univ Sci Technolog Med Sci; 2007 Feb; 27(1):65-7. PubMed ID: 17393113
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 3,3'-diindolylmethane enhances the efficacy of butyrate in colon cancer prevention through down-regulation of survivin.
    Bhatnagar N; Li X; Chen Y; Zhou X; Garrett SH; Guo B
    Cancer Prev Res (Phila); 2009 Jun; 2(6):581-9. PubMed ID: 19470789
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regulation of survivin expression by IGF-1/mTOR signaling.
    Vaira V; Lee CW; Goel HL; Bosari S; Languino LR; Altieri DC
    Oncogene; 2007 Apr; 26(19):2678-84. PubMed ID: 17072337
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Survivin as a target for new anticancer interventions.
    Zaffaroni N; Pennati M; Daidone MG
    J Cell Mol Med; 2005; 9(2):360-72. PubMed ID: 15963255
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Validation of telomerase and survivin as anticancer therapeutic targets using ribozymes and small-interfering RNAs.
    Zaffaroni N; Pennati M; Folini M
    Methods Mol Biol; 2007; 361():239-63. PubMed ID: 17172716
    [TBL] [Abstract][Full Text] [Related]  

  • 59. SPC3042: a proapoptotic survivin inhibitor.
    Hansen JB; Fisker N; Westergaard M; Kjaerulff LS; Hansen HF; Thrue CA; Rosenbohm C; Wissenbach M; Orum H; Koch T
    Mol Cancer Ther; 2008 Sep; 7(9):2736-45. PubMed ID: 18790754
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sequential combination of flavopiridol with Taxol synergistically suppresses human ovarian carcinoma growth.
    Song Y; Xin X; Zhai X; Xia Z; Shen K
    Arch Gynecol Obstet; 2015 Jan; 291(1):143-50. PubMed ID: 25118834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.